Lorcaserin (Belviq) approved by FDA for weight loss

view story

http://www.itwire.com – The U.S. Food and Drug Administration has approved the drug lorcaserin as a prescription anti-obesity medication. Used in combination with a healthy diet and regular exercise, the FDA hopes the new weight-loss medicaiton will help people lose weight and live a healthier lifestyle. {loadposition william08}The next step in the process is for the Drug Enforcement Administration to approve its sale in the United States. Once this is done, the drug will be marketed under the name Belviq. The anti-obesity drug will then be approved to be sold to adults with (1) a body mass index (BMI ()